Pharmacovigilance Awareness Program for ASU&H Drugs at Alvas HMC
An awareness program on pharmacovigilance in
ASU&H Drugs was held at MBA Auditorium of Alva's Homeopathic Medical
College, Mijar -Moodbidri on March 21, 2024,
The event commenced with a soulful rendition
by the college choir team, invoking a sense of reverence and harmony.
Dr Deepak R D extended a warm welcome to all
attendees, emphasizing the importance of pharmacovigilance in ensuring drug
safety and efficacy.
An elegant floral welcome was extended to the
speakers and dignitaries by the master of ceremonies, adding a touch of grace
to the event.Symbolizing the illumination of knowledge and wisdom, dignitaries
ceremoniously lit the lamp, marking the auspicious beginning of the programme.
Dr Roshan Pinto, the president of the event,
shared insightful remarks on the significance of pharmacovigilance in
alternative systems of medicine, highlighting the need for rigorous monitoring
and reporting of adverse drug reactions.
Dr Vivek Sakthidharan's session on adverse
drug reactions and adverse drug events in the Ayurveda, Siddha, and Unani
system provided valuable insights into the complexities of pharmacovigilance
within alternative systems of medicine. His expertise and engaging presentation
style enriched the audience's understanding of the challenges and importance of
monitoring drug safety in traditional healing practices.
Dr Fathima Soudath, delivered an enlightening
presentation on the Drug and Magic Remedies (Objectionable Advertisements) Act
and the prevalence of misleading advertisements in the healthcare industry. Her
session aimed to raise awareness about the regulatory framework governing
advertising practices and the implications of misleading promotions on public
health. Her comprehensive overview and illustrative examples underscored the
importance of promoting ethical advertising standards and safeguarding public
health from deceptive promotions.
The session concluded with a lively
discussion and Q&A segment, during which participants engaged with the
speakers to clarify doubts and share
their perspectives on Adverse Drug Reactions and addressing misleading
advertisements. Overall, presentations
served as a catalyst for raising awareness and fostering collaboration in
upholding integrity and transparency in healthcare advertising practices and
continued dialogue and collaboration in advancing pharmacovigilance efforts
within the ASU system.
The event boasted an impressive turnout, with
a total of 392 participants in attendance. This significant number reflects the
widespread interest and importance attributed to the topic of Pharmacovigilance
in alternative systems of medicine and the regulatory framework surrounding
healthcare advertising. The diverse audience contributed to enriching
discussions and facilitated a fruitful exchange of ideas throughout the
duration of the awareness programme.
As a token of appreciation, mementos were
presented to the esteemed speakers by the master of ceremonies, acknowledging
their valuable contributions to the awareness programme.
Ms. Smitha expressed gratitude to all
participants, speakers, organizers, and sponsors for their collective efforts
in making the awareness programme a resounding success. She emphasized the role
of continued education and collaboration in promoting drug safety and public
health.
